Inventor
Chuangen TANG
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes17%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture17%
C12YEnzymes17%
A61KPreparations for medical, dental or toiletry purposes11%
C07KPeptides11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
C07HSugars6%
C08BPolysaccharides6%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms6%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
12,325,732Pro-insulin aspart structure and method for preparing insulin aspart202512,202,874Fusion protein and its preparation method for intermediate polypeptide of Semaglutide202511,667,901Chondrosulphatase and use thereof202311,572,421Low molecular weight chondroitin sulfate, composition, preparation method and use thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to NANJING HANXIN PHARMACEUTICAL TECH CO LTD (2)· patent assignee history
2023Patents assigned to NANJING HANXIN PHARMACEUTICAL INC (1)· patent assignee history
2023–2025Based in CN· patent location history
2025Patents assigned to AMPHASTAR NANJING PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NANJING HANXIN PHARMACEUTICAL TECH CO LTD | 2 | 2023–2025 |
| AMPHASTAR NANJING PHARMACEUTICALS INC | 1 | 2025 |
| NANJING HANXIN PHARMACEUTICAL INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2023–2025 |